18th week of 2017 patent applcation highlights part 10 |
Patent application number | Title | Published |
20170119806 | ARYLNAPHTHALENE LACTONE DERIVATIVES AND METHODS OF MAKING AND USING THEREOF | 2017-05-04 |
20170119807 | MACROCYCLIC LACTONES AND USES THEREOF AS MODULATORS OF PURINERGIC RECEPTORS | 2017-05-04 |
20170119808 | EXTENDED-RELEASE TOPIRAMATE CAPSULES | 2017-05-04 |
20170119809 | Combination Therapy Using Ribavirin As eIF4E Inhibitor | 2017-05-04 |
20170119810 | METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS | 2017-05-04 |
20170119811 | SURFACE TREATMENT OF CONTACT LENS AND TREATMENT OF OCULAR DISCOMFORT BY WATER SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES | 2017-05-04 |
20170119812 | Product for and Method of Protecting and Increasing Friction of Animal Paws | 2017-05-04 |
20170119813 | BIODEGRADABLE POLYESTERAMIDE USED FOR THE TREATMENT OF ARTHRITIC DISORDERS | 2017-05-04 |
20170119814 | THERAPEUTIC NANOPARTICLES AND METHODS THEREOF | 2017-05-04 |
20170119815 | CALCIUM CARBONATE COMPOSITION FOR AMELIORATING, PREVENTING AND TREATING OSTEOPOROSIS, AND MANUFACTURING METHOD THEREFOR | 2017-05-04 |
20170119816 | COLONOSCOPY - PREPARATION | 2017-05-04 |
20170119817 | METHODS AND COMPOSITIONS FOR TREATING AND/OR INHIBITING TOXINS USING COPPER-CONTAINING COMPOUNDS | 2017-05-04 |
20170119818 | ANTICANCER NANO-SILVER COMPOSITION FOR TREATMENT OF LUNG CANCER, AND PREPARATION METHOD AND USE THEREOF | 2017-05-04 |
20170119819 | COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF GRAFTS | 2017-05-04 |
20170119820 | MODIFIED CELLS AND METHODS OF THERAPY | 2017-05-04 |
20170119821 | ANTI-TUMOR T CELL IMMUNITY INDUCED BY HIGH DOSE RADIATION | 2017-05-04 |
20170119822 | METHODS FOR TREATING OBESITY AND/OR METABOLIC SYNDROME | 2017-05-04 |
20170119823 | METHOD FOR NON SURGICAL REPAIR OF VERTEBRAL COMPRESSION FRACTURES | 2017-05-04 |
20170119824 | A METHOD FOR THE TREATMENT OF GLIOBLASTOMA WITH WHARTON JELLY-MESENCHYMAL STEM CELLS (WJ-MSC) DERIVED FROM HUMAN UMBILICAL CORD | 2017-05-04 |
20170119825 | BONE FORMATION PROMOTER | 2017-05-04 |
20170119826 | ACELLULAR SOFT TISSUE-DERIVED MATRICES AND METHODS FOR PREPARING SAME | 2017-05-04 |
20170119827 | Method and System to Improve the Health of a Person's Skin Microbiome | 2017-05-04 |
20170119828 | LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF | 2017-05-04 |
20170119829 | METHOD FOR INDUCING PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR | 2017-05-04 |
20170119830 | TARGETED ADENOVIRUSES AND METHODS OF MAKING, ISOLATING, AND USING | 2017-05-04 |
20170119831 | USE OF HYDROTHERMALLY TREATED BIOMASS AS PATHOGEN BINDER | 2017-05-04 |
20170119832 | Topical Ointment to Treat Inflammatory Conditions such as Shingles | 2017-05-04 |
20170119834 | Methods of Treating Diarrhea in Adult Non-Human Animals | 2017-05-04 |
20170119835 | METHOD OF MAKING AN ADJUNCT TO POTENTIATE BLOCKING OF RIBOSOMAL FUNCTIONS IN TUMOR CELLS AND PREVENT BODY WEIGHT LOSS DURING CYCLOPHOSPHAMIDE CANCER THERAPY | 2017-05-04 |
20170119836 | METHOD OF MAKING A LIQUID COMPOSITION | 2017-05-04 |
20170119837 | DIETARY SUPPLEMENT | 2017-05-04 |
20170119838 | REMEDY FOR GASTRITIS AND GASTRIC ULCER | 2017-05-04 |
20170119839 | METHOD FOR PREPARING GARLIC-FERMENTED COMPOSITION AND GARLIC-FERMENTED COMPOSITION PREPARED BY SAME METHOD | 2017-05-04 |
20170119840 | LISINOPRIL FORMULATIONS | 2017-05-04 |
20170119841 | AMINO ACID SALTS OF UNSATURATED FATTY ACIDS | 2017-05-04 |
20170119842 | Pharmaceutical Compositions with Enhanced Stability | 2017-05-04 |
20170119843 | COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY | 2017-05-04 |
20170119844 | HEMOSTATIC PHARMACEUTICAL COMPOSITION | 2017-05-04 |
20170119845 | CHLORIDE SALT OF TAT-NR2B9C | 2017-05-04 |
20170119846 | METHOD AND KIT FOR BOWEL PREPARATION | 2017-05-04 |
20170119847 | SHORT BETA-DEFENSIN-DERIVED PEPTIDES | 2017-05-04 |
20170119848 | COMPOSITION AND METHOD FOR THE TREATMENT OR PREVENTION OF SPINAL DISORDERS | 2017-05-04 |
20170119849 | Therapy of Cardiomyopathy by Intramyocardial Cell Delivery and Cytokine Administration | 2017-05-04 |
20170119850 | METHOD FOR TREATING CHEMOTHERAPY-INDUCED MALE INFERTILITY | 2017-05-04 |
20170119851 | METHODS OF TREATING ANOREXIA | 2017-05-04 |
20170119852 | USE OF AVE0010 FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 | 2017-05-04 |
20170119853 | Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites | 2017-05-04 |
20170119854 | HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF | 2017-05-04 |
20170119855 | STABLE NON-AQUEOUS SINGLE PHASE VISCOUS VEHICLES AND FORMULATIONS UTILIZING SUCH VEHICLES | 2017-05-04 |
20170119856 | ADMINISTRATION ROUTES OF INSULIN, INSULIN ANALOGS OR DERIVATIVES OF INSULIN | 2017-05-04 |
20170119857 | Method of Administering Porcine B-Domainless fVIII | 2017-05-04 |
20170119858 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE TOLERANCE | 2017-05-04 |
20170119859 | TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS | 2017-05-04 |
20170119860 | ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE | 2017-05-04 |
20170119861 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS | 2017-05-04 |
20170119862 | HUMAN TISSUE KALLIKREIN 1 GLYCOSYLATION ISOFORMS | 2017-05-04 |
20170119863 | NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT | 2017-05-04 |
20170119864 | SACCHARIDE VACCINE FORMULATION | 2017-05-04 |
20170119865 | METHOD OF EXPANDING NK CELL AND COMPOSITION FOR CULTURING | 2017-05-04 |
20170119866 | FUSION MOLECULE BASED ON NOVEL TAA VARIANT | 2017-05-04 |
20170119867 | A VACCINE COMPOSITION AND USES THEREOF | 2017-05-04 |
20170119868 | ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN | 2017-05-04 |
20170119869 | Dengue Virus Specific Multiple HLA Binding T Cell Epitopes For The Use Of Universal Vaccine Development | 2017-05-04 |
20170119870 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS (CSFV) COMPRISING SUBSTITUTION IN THE TAV EPITOPE OF THE E2 PROTEIN | 2017-05-04 |
20170119871 | LOW-ADDITIVE INFLUENZA VACCINES | 2017-05-04 |
20170119872 | SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES | 2017-05-04 |
20170119873 | SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE | 2017-05-04 |
20170119874 | HUMAN CYTOMEGALOVIRUS VACCINE COMPOSITIONS AND METHOD OF PRODUCING THE SAME | 2017-05-04 |
20170119875 | AMINO SPHINGOGLYCOLIPID ANALOGUES | 2017-05-04 |
20170119876 | USE OF RECOMBINANT LAG-3 OR THE DERIVATIVES THEREOF FOR ELICITING MONOCYTE IMMUNE RESPONSE | 2017-05-04 |
20170119877 | USE OF VISTA AGONISTS AND ANTAGONISTS TO SUPPRESS OR ENHANCE HUMORAL IMMUNITY | 2017-05-04 |
20170119878 | METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASES CAUSED BY OR ASSOCIATED WITH HIV | 2017-05-04 |
20170119879 | COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH NEURODEGENERATIVE DISEASES | 2017-05-04 |
20170119880 | COMPOSITIONS AND METHODS FOR CHARACTERIZING, REGULATING, DIAGNOSING, AND TREATING CANCER | 2017-05-04 |
20170119881 | COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND MICROTUBULES | 2017-05-04 |
20170119882 | COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS | 2017-05-04 |
20170119883 | COMBINATION THERAPIES USING PLATINUM AGENTS AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS | 2017-05-04 |
20170119884 | Drug having steroids and fatty compound | 2017-05-04 |
20170119885 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES | 2017-05-04 |
20170119886 | ELECTROSPUN FIBERS HAVING CONTRAST AGENTS AND METHODS OF MAKING THE SAME | 2017-05-04 |
20170119887 | LIPID PARTICLES AND NUCLEIC ACID DELIVERY CARRIER | 2017-05-04 |
20170119888 | PRESERVED COMPOSITIONS CONTAINING HYALURONIC ACID OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF AND RELATED METHODS | 2017-05-04 |
20170119889 | POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | 2017-05-04 |
20170119890 | PH-SENSITIVE AND BIOREDUCIBLE POLYMER-VIRUS COMPLEX FOR CANCER TREATMENT | 2017-05-04 |
20170119891 | NANOSTRUCTURED CARRIERS FOR GUIDED AND TARGETED ON-DEMAND SUBSTANCE DELIVERY | 2017-05-04 |
20170119892 | REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF | 2017-05-04 |
20170119893 | Derivatisation of Erythropoietin (EPO) | 2017-05-04 |
20170119894 | METHODS AND COMPOSITIONS FOR IMPROVING MICROVASCULAR FUNCTION, SUPPRESSING CYCLOOXYGENASE ACTIVITY, REDUCING PLATELET AGGREGATION AND INCREASING LEVELS OF RESVERATROL IN PLASMA | 2017-05-04 |
20170119895 | COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY | 2017-05-04 |
20170119896 | TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF | 2017-05-04 |
20170119897 | DENDRIMER COMPOSITIONS AND USE IN TREATMENT OF NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL DISORDERS | 2017-05-04 |
20170119898 | HYPERBRANCHED POLYGLYCEROL SULFATES WITH HYDROPHOBIC CORES | 2017-05-04 |
20170119899 | COMPOSITIONS AND METHODS FOR TREATMENT OF PEROXISOMAL DISORDERS AND LEUKODYSTROPHIES | 2017-05-04 |
20170119900 | Peptide, Complex of Peptide and SiRNA and Use Thereof | 2017-05-04 |
20170119901 | FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETO | 2017-05-04 |
20170119902 | ANTIBODY-DRUG CONJUGATE (ADC) AND METHOD FOR FORMING THE SAME | 2017-05-04 |
20170119903 | MODIFIED ANTIBODY IN WHICH MOTIF COMPRISING CYSTEINE RESIDUE IS BOUND, MODIFIED ANTIBODY-DRUG CONJUGATE COMPRISING THE MODIFIED ANTIBODY, AND PRODUCTION METHOD FOR SAME | 2017-05-04 |
20170119904 | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | 2017-05-04 |
20170119905 | AII RETINAL AMACRINE CELL-SPECIFIC PROMOTER | 2017-05-04 |
20170119906 | LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF | 2017-05-04 |